Serum microRNA-221 as a biomarker for diabetic retinopathy in patients associated with type 2 diabetes
Author(s) -
Henan Liu,
Xun Li,
Na Wu,
Mengmeng Tong,
Shuo Chen,
Shanshan Zhu,
Qian Wei,
Xiaolong Chen
Publication year - 2018
Publication title -
international journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 29
eISSN - 2227-4898
pISSN - 2222-3959
DOI - 10.18240/ijo.2018.12.02
Subject(s) - medicine , diabetic retinopathy , glycated hemoglobin , type 2 diabetes , diabetes mellitus , biomarker , endocrinology , vascular endothelial growth factor , retinopathy , insulin resistance , receiver operating characteristic , gastroenterology , vegf receptors , biochemistry , chemistry
To investigate the candidate microRNA (miRNA), miR-221 as a novel biomarker for diabetic retinopathy (DR) in patients associated with type 2 diabetes (T2D).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom